Ocugen pays $15 mn upfront to Bharat Biotech for Covaxin rights in Canada

Similar to the US arrangement, Ocugen will retain 45 per cent of the profit from sales of Covaxin in Canada.

from The Hindu - Business https://ift.tt/3iugfVV
via IFTTT

Post a Comment

0 Comments